Per Deborah’s Instructions, Message to All SCAN Cells by Kerth Barker

Most of what I write here in this article is only going to make sense to SCAN members. And this article is really only written for SCAN members. But I’ll explain this much to anyone else who happens to read this.

Certain SCAN members monitor this thoughtcrime website on a regular basis, looking for new articles by me. When they spot such articles, they share copies of the articles with the SCAN leaders of the various cells that make up SCAN. So this is a method of dissemination to cell leaders.

I don’t have much to say these days that would be of interest to SCAN leaders, as they generally know more about what’s going on than I do. But I do have one last thing to say that would be of interest to them. So this new article, posted on March 29th, 2020, is significant to the SCAN monitors.

Precognitive persons, “cogs”, think differently than most earthlings. Cog leaders, like Deb, have their own logic that must be respected, if not understood, by those of lesser cog ability, such as myself.

So when Deb gave me certain specific instructions, like the friend of SCAN that I am, I decided to follow them exactly rather than question them. She gave me these instructions a number of years ago, but I have followed them. The instructions given to me by Deborah were this:

“When the seven books of Kerth Barker have been finally completed, with all appendixes, postscripts and whatnots, post this fact on thoughtcrimeradio under the Kerth Barker pen name.”

“You need to get this all done by the early part of 2020.”

“Before the various SCAN cells all went independent, they were instructed to prepare to take certain time-coordinated actions to be triggered by the announcement of these books’ completion.”

“Before our leader left, he said he would return. He said that to know when the time of his return was at hand, we were to look for certain signs that he described to us. All of these other signs have been met. The final sign is this announcement, that you will make.”

“So once you make this announcement, on that thoughtcrime site, all of the independent cells will become fully prepared to act upon our leader’s return.”

“Tell no other person of this until after you have assured the completion of the seven Kerth Barker books. Until you make the announcement, no one else must know of its significance. This is the last thing I ask from you.”

Using automatic-writing SOP, I’ve been able to recall my conversation with Deb, that took place years ago. And I’m posting this article per her instructions. So now I can announce that the seven Kerth Barker books, that James and Deb wanted me to write and publish, have been put out in their final versions.

I don’t know what the independent SCAN cells are going to do exactly in response to this announcement. And I don’t know what Deb meant when she said that SCAN’s leader is going to return. James was SCAN’s founder and leader until the announcement of his death. Although it was generally believed that James had died, I don’t know if anyone found his body. Maybe he will return to lead SCAN. But SCAN leaders also believe that Jesus Christ is the ultimate leader of SCAN. So maybe Deb is talking about the Second Coming of Christ. Or maybe this was a coded message, I don’t know for sure what this means. If you’re in SCAN, you probably know more about what this means than I do.

But I feel safe cooperating with SCAN this one last time because I trusted James and I trust Deb. She trusted me to do this, and so it’s done.

Beware Chinese Coronavirus Test Kits

The Daily Mail reports that “Mr Johnson has been warned by scientific advisers that China’s officially declared statistics on the number of cases of coronavirus could be ‘downplayed by a factor of 15 to 40 times.’”

“There is a disgusting disinformation campaign going on and it is unacceptable,” an anonymous government source told The Mail. “They [the Chinese government] know they have got this badly wrong and rather than owning it they are spreading lies.”

“It is going to be back to the diplomatic drawing board after this. Rethink is an understatement,” another government source said, with a further source adding that “There has to be a reckoning when this is over.”

The British government also “believes China is seeking to build its economic power during the pandemic with ‘predatory offers of help’ [to] countries around the world.’” the report continues.

China has been delivering hundreds of thousands of testing kits and masks to nations around the world. One problem, however, is that they don’t work.

“In Spain, which currently has the fourth-highest number of coronavirus cases in the world, the government purchased 640,000 rapid test kits from China and South Korea as it fights the pandemic,” The Free Beacon reported this week.

“Experts soon discovered, however, that the tests it purchased from Chinese company Bioeasy were only correctly identifying coronavirus cases 30 percent of the time, according to Spain’s El Pais.” the report notes.

“The Czech Republic also purchased 150,000 rapid test kits from China, and have likewise found problems.” the report continues, adding that  “One doctor using the tests found that 80 percent of the kits were faulty and has reverted back to the conventional lab tests, which are significantly slower to process.”

Other countries such as Turkey and Georgia, as well as Holland have reported problems with the tests and the masks….

Why is the CDC ‘sitting on the sidelines’ in the Covid-19 fight?

The public health challenge of our generation is right in front of us. SARS-CoV-2 appears to be the Andromeda strain that public health workers fear to see emerging. After many years of working at the Centers for Disease Control and Prevention, I’m perplexed, and saddened, that the agency seems to be sitting on the sidelines for this pandemic and is not building on the accumulated skills and experience from its past.

Nobody dismisses the worsening crisis or its ability to deal a potentially deadly blow to health systems and economies around the world. Health care providers throughout the U.S., emulating those in other countries, are improvising protective equipment. Bandanas are the new N95 face masks. Clinicians and other providers wait days or weeks to get the results of nasal swabs collected at great risk from patients suspected to have Covid-19. From nurseries to universities, from small businesses to large corporations, nearly everybody is, or likely will soon be, quarantined, locked down, and rightfully scared.

For decades, the CDC has been at the forefront of responding quickly to new and emerging disease threats. During previous outbreaks, teams of responders have been quickly deployed in the U.S., at the request of one or more states, as well as in remote and sometimes socially unstable places at the request of foreign governments. The mission of these teams is to guide and support local, national and international public health response efforts.

In the spring of 1993, an unknown disease was detected in the Four Corners region of Colorado, Utah, Arizona, and New Mexico. A CDC team was dispatched to the area. In just a few weeks, CDC scientists had not only identified and described a new hantavirus, but they also created a diagnostic test for laboratories. By the end of 1993, patients were found in multiple states and tens of thousands of blood samples had been run in one of CDC’s laboratories.

During the 2014-2016 Ebola outbreak, the CDC enlisted thousands of responders from the U.S. and various affected African countries, and staffed a laboratory first in Kenema, and then in Bo, Sierra Leone that conducted more than 16,000 Ebola tests under difficult local conditions.

Over the decades, CDC workers developed many new diagnostic assays during emergencies to respond promptly to new or orphan diseases.

Annual funding cycles and conflicting priorities have challenged the CDC’s ability to maintain expertise and replenish human resources. New layers of bureaucracy, created in the late 2000s, fostered increased top-down regulation, slowing or blocking initiative and innovation. Productivity declined as research and clinical laboratories were saddled with strict and complicated Clinical Laboratory Improvement Amendments (CLIA) rules and an insistence on FDA-approved tests — even for tests developed and run only in CDC reference laboratories.

Each year supervisors must take mandatory leadership training courses regardless of their demonstrated skills and experience. Instead of mentoring younger generations at the bench, laboratory managers and leaders spend much of their time in the office to working on time-consuming lab-related paperwork and seeking clearer explanations of new regulations….

The use of other diagnostic assays for SARS-CoV-2, including one recommended by the World Health Organization, were blocked in the U.S. by the Food and Drug Administration, pending the Emergency Use Authorization. The belated recognition by the Department of Health and Human Services and the U.S. government of the gravity of the Covid-19 outbreak resulted in new requests and rules for the Atlanta-based CDC. The inevitable politicization of the response added further challenges. The CDC is, after all, a governmental agency….

Inexplicably, offers by CDC laboratorians to volunteer for the Covid-19 response and support the coronavirus laboratory with added manpower were refused by CDC administrators, who seem incapable of understanding the dire situation occurring outside the organization’s gates, hiding behind cumbersome regulations developed for peacetime settings…

SARS-CoV-2 Coronavirus Is Mutating Into Dozens of Strains

Coronavirus research:  A new non-peer reviewed study published in the open platform MedRvix indicates that the SARS-Cov-2 coronavirus could be evolving or mutating into various strains with each a different mode of attacking or binding to human host cells and with different infected patients varying symptoms and effects.

In this new study alone, 49 new strains were identified and one strain in particularly that was identified as the ZJ01 Strain was completed different from the earlier strains that were first identified in Wuhan.

The earlier strain basically attacked human host cells using the ACE-2 receptors whereas the new strain had a preference for binding via the Furin cleavage site.

Thailand Medical News had already earlier already covered other studies showing that the SARS-CoV-2 coronavirus has to date four discovered modes of attacking or binding to human host cells.(,-making-it-a-truly-potent-coronavirus-that-is-in-a-league-of-its-own) and (

The Phylogenetic analysis suggested that SARS-CoV-2 exhibited remarkable evolutionary divergence, with potential evolutionary branches within SARS-CoV-2.

During the initial Wuhan epidemic, there were 2 main strains the, WIV02 (2019-12-31)/WH19008 (2019-12-30) and MT0270641 (2020-1-29)/ZJ01(2020-1-23) and these were the basis for  the potential of forming evolutionary branches during dissemination.

Later just in China alone, 8 strains were identified. The relative synonymous codon usage (RSCU) analysis showed that there were various differences among 8 strains (MN938384, CNA0007334, WIV06, ZJ01, NMDC60013002-05, CNA0007332, MN988668, WIV07) and other members of SARS-CoV-2 family (Fig 1B), where MN938384, CNA0007334, WIV06 and ZJ0. Among aforementioned 8 strains which were collected in Wuhan, Guangdong and Hangzhou, six were collected at the early stage of COVID-19 (2019-12-26 to 2020 -1-2). The collection time of MN938384 was no later than 2020-1-14 (virus submission time), while ZJ01 was collected on 2020-1-23.

ZJ01, including 7 deletions, 4 insertions and 24 substitutions. For the rest 3 mutation sites, NO.20 was caused by a sequencing error while NO.14 and No. 38 widely existed in SARS-CoV-2 family. Among ZJ01 unique mutations, 10 (NO.22-31) were located on the S protein, including 3 samesense mutation, 2 deletion mutation and 5 missense mutation, which led to amino acid changes of Ser596, Gln613, Glu702, Ala771, Ala1015, Pro1053 and Thr1066. Further similarity analysis indicated that the main difference among various coronaviruses located in the Receptor Binding Domain (RBD) region of S1. Intriguingly, the differences between ZJ01 and other members of SARS-CoV-2 mainly resided in in the S1/S2 and S2 (please refer to detailed diagrams in the study.)

The new evolved ZJ01 strain has a better affinity of binding to the furin-cleavage sites and it produced milder symptoms in the infected patients and less damage to the lungs and kidneys. However researchers warned although the patients from these strains recovered faster, the midterm and long term effects of the residual viral loads or dormant loads in the patients could be more harmful in the future but studies are needed to carefully observe and conclude that.

Also these new discoveries and studies about the various new mutations could have repercussions of drug and vaccine development.

We at Thailand Medical News are very confused as to why the WHO or any research entities or medical entities are not mentioning about this mutations and various strains being formed at such a rapid phase and why we too have been warned by certain authorities to stop making research data available to the general public. There are currently many other studies, some peer reviewed that has confirmed that the virus is actually mutating at a rapid stage and contrary to the initial information we were fed and also there are more than 49 strains at the moment, some with distinct characteristics.

We are Thailand Medical News will be covering more on this over the next few days.

For the latest on coronavirus research, keep logging on to Thailand Medical News

Additional Research Sources: (apologies as we missed them, the first time but are gradually adding all the various references, there are not just 10 but more, please give us some time to place all of them here gradually in the next few hours)

International expansion of a novel SARS-CoV-2 mutant
Minjin Wang, Mengjiao Li, Ruotong Ren, Andreas Brave, Sylvie van der Werf, En-Qiang Chen, Zhiyong Zong, Weimin Li, Binwu Yingdoi:

Evidence of the Recombinant Origin and Ongoing Mutations in Severe Acute Respiratory Syndrome 2 (SARS-COV-2)
Jiao-Mei Huang, Syed Sajid Jan, Xiaobin Wei, Yi Wan,  View ORCID ProfileSongying Ouyang

RBD mutations from circulating SARS-CoV-2 strains enhance the structure stability and infectivity of the spike protein
Junxian Ou, Zhonghua Zhou, Jing Zhang, Wendong Lan, Shan Zhao, Jianguo Wu, Donald Seto, Gong Zhang, Qiwei Zhang

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran
 View ORCID ProfileJohn-Sebastian Eden, Rebecca Rockett, Ian Carter, Hossiner Rahman, Joep de Ligt, James Hadfield, Matthew Storey, Xiaoyun Ren, Rachel Tulloch, Kerri Basile, Jessica Wells, Roy Byun, Nicky Gliroy, Matthew V O’Sullivan, Vitali Sintchenko, Sharon C Chen, Susan Maddocks, Tania C Sorrell, Edward C Holmes, Dominic E Dwyer, Jen Kok

Good news! US Autism Rates Up Nearly 10%

US Autism Rates Up Nearly 10%, But This May Be a Good Thing

US autism rates have increased nearly 10% over a 4-year period, new research from the Centers for Disease Control and Prevention (CDC), show.

However, this increase is likely because of continued progress in early screening and diagnosis, and improved detection in minority groups, the CDC said today. …

This is the kind of crap the medical journals are shoveling at american doctors.   And apparently they’re buying it.